Heparin-induced thrombocytopenia: Towards standardization of platelet factor 4/heparin antigen tests

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 9, 2010, Pages 2025-2031

  Greinacher, A ^a   Ittermann, T ^a   Bagemuhl J ^a   Althaus, K ^a   Furll B ^a   Selleng, S ^a   Lubenow, N ^a   Schellong, S ^b   Sheppard, J I ^c   Warkentin, T E ^c  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Heparin; Heparin induced thrombocytopenia; Laboratory testing; Platelets

Indexed keywords

HEPARIN; IMMUNOGLOBULIN G; THROMBOCYTE ANTIBODY; THROMBOCYTE FACTOR 4;

ADULT; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GROUPS BY AGE; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; MALE; NORMAL HUMAN; OPTICAL DENSITY; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEROTONIN RELEASE; SEX DIFFERENCE; STANDARDIZATION; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA;

ADULT; AGED; FEMALE; HEPARIN; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PLATELET FACTOR 4; REFERENCE VALUES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RISK; SEROTONIN; SEX FACTORS; THROMBOCYTOPENIA;

EID: 77956483253     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03974.x     Document Type: Article

References (15)

1. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 1998, 79:1-7.
2. Greinacher A, Warkentin TE. Treatment of heparin-induced thrombocytopenia: an overview. Heparin-Induced Thrombocytopenia 2007, 283-318. In, 3rd edn, New York, Marcel Dekker, Inc
3. Warkentin TE, Sheppard JA. Testing for heparin-induced thrombocytopenia antibodies. Transfus Med Rev 2006, 20:259-72.
4. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986, 67:27-30.
5. Greinacher A, Michels I, Kiefel V, Mueller-Eckhardt C. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemost 1991, 66:734-6.
6. Eichler P, Budde U, Haas S, Kroll H, Loreth RM, Meyer O, Pachmann U, Potzsch B, Schabel A, Albrecht D, Greinacher A. First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet-activation test (HIPA) in comparison with a PF4/heparin ELISA. Thromb Haemost 1999, 81:625-9.
7. Zwicker JI, Uhl L, Huang WY, Shaz BH, Bauer KA. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost 2004, 2:2133-7.
8. Warkentin TE, Sheppard JI, Moore JC, Sigouin CS, Kelton JG. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. J Thromb Haemost 2008, 6:1304-12.
9. Juhl D, Eichler P, Lubenow N, Strobel U, Wessel A, Greinacher A. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia. Eur J Haematol 2006, 76:420-6.
10. Lubenow N, Hinz P, Thomaschewski S, Lietz T, Vogler M, Ladwig A, Junger M, Nauck M, Schellong S, Wander K, Engel G, Ekkernkamp A, Greinacher A. The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia. Blood 2010, 115:1797-803.
11. Schellong S, Haas S, Greinacher A, Sieder C, Abletshauser C, Riess H. Thromboprophylaxis with certoparin in acutely ill, non-surgical patients - certain study. Hämostaseologie 2009, 29:A90. abstract)
12. Selleng S, Malowsky B, Strobel U, Wessel A, Ittermann T, Wollert HG, Warkentin TE, Greinacher A. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia even when antibody tests are positive. J Thromb Haemost 2010, 8:30-6.
13. Greinacher A, Juhl D, Strobel U, Wessel A, Lubenow N, Selleng K, Eichler P, Warkentin TE. Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes. J Thromb Haemost 2007, 5:1666-73.
14. Koenker R. Quantile Regression 2005, New York, Cambridge Press
15. Duxbury BM, Poller L. The oral anticoagulant saga: past, present, and future. Clin Appl Thromb Hemost 2001, 7:269-75.